Metformin may prevent a common cause of vision loss in aging
By
Alicia Lasek
Feb 01, 2021
The diabetes drug metformin may protect against age-related macular degeneration, a potentially blinding condition for which there appears to be no effective preventive measures, researchers contend.
Veterans more likely to lose a limb to chronic disease than battle, study finds
By
Alicia Lasek
Jan 27, 2021
An analysis of health records from veterans up to age 76 show that peripheral arterial disease and diabetes are prevalent in amputees, while trauma is rarely a cause of amputation.
NSAIDs may raise risk of kidney injury in patients with diabetes
By
Alicia Lasek
Jan 21, 2021
Short-term use of NSAIDs, which include ibuprofen, aspirin and naproxen, is linked to kidney damage and high potassium levels, researchers have found.
Clinical briefs for Tuesday, Jan. 12
By
Alicia Lasek
Jan 12, 2021
The COVID picture at 6 months: Symptoms patients face after leaving the hospital … New CDC study confirms community link to COVID rate in residents, staff … Nurse-led intervention encourages advance...
All prediabetes is not alike: 6 subtypes help predict risk, prevent poor outcomes
By
Alicia Lasek
Jan 05, 2021
A clear new classification of prediabetes subtypes can help clinicians identify their most at-risk patients and aid in developing targeted therapies to prevent progression to diabetes, researchers report.
FDA approves first generic of glucagon to treat severe low blood sugar
By
Alicia Lasek
Jan 04, 2021
Glucagon to treat severe hypoglycemia is available in a generic formula for the first time in 20 years.
Clinical briefs for Monday, Dec. 7
By
Alicia Lasek
Dec 07, 2020
Researchers urge priority vaccination for individuals with diabetes … AstraZeneca vaccine approval iffy in U.S. with current data, OWS scientist says … WHO trial finds no benefit of 4 drugs for hospitalized...
MedDiet cuts diabetes risk by a third in 25-year Women’s Health Study
By
Alicia Lasek
Nov 23, 2020
The Mediterranean diet reduces diabetes risk by 30% in women who are considered clinically overweight or obese, a new analysis of long-term data finds.
Clinical briefs for Monday, Nov. 16
By
Alicia Lasek
Nov 16, 2020
A few pounds of weight loss nearly halves diabetes risk, large-scale study finds … FDA: Only N95s are nearly 100% effective, but cloth masks also protective … Link between gut microbiome and risk of...
Among short-lived diabetes treatments, a combo therapy lasts
By
Alicia Lasek
Nov 04, 2020
Dual treatment with the glucose-lowering drugs dapagliflozin and exenatide remains effective for patients with diabetes after two years of continual use, according to the results of a late-stage clinical...